778 related articles for article (PubMed ID: 18806702)
21. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.
Guglielmetti S; Mora D; Gschwender M; Popp K
Aliment Pharmacol Ther; 2011 May; 33(10):1123-32. PubMed ID: 21418261
[TBL] [Abstract][Full Text] [Related]
22. Clinical studies on alleviating the symptoms of irritable bowel syndrome.
Kajander K; Korpela R
Asia Pac J Clin Nutr; 2006; 15(4):576-80. PubMed ID: 17077079
[TBL] [Abstract][Full Text] [Related]
23. Probiotics and functional gastrointestinal disorders in children.
Vandenplas Y; Benninga M
J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S107-9. PubMed ID: 19300120
[TBL] [Abstract][Full Text] [Related]
24. Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: a randomized, placebo-controlled trial.
Søndergaard B; Olsson J; Ohlson K; Svensson U; Bytzer P; Ekesbo R
Scand J Gastroenterol; 2011 Jun; 46(6):663-72. PubMed ID: 21443416
[TBL] [Abstract][Full Text] [Related]
25. New insights into Lactobacillus and functional intestinal disorders.
Lombardo L
Minerva Gastroenterol Dietol; 2008 Sep; 54(3):287-93. PubMed ID: 18614977
[TBL] [Abstract][Full Text] [Related]
26. Failure to define what constitutes a patient responder is a problem in the interpretation of the probiotic clinical trial evaluating the use of Bifidobacterium in irritable bowel syndrome.
van Zanten SV
Gastroenterology; 2005 Aug; 129(2):772; author 772-3. PubMed ID: 16083745
[No Abstract] [Full Text] [Related]
27. Bacterial overgrowth as a cause of irritable bowel syndrome.
Riordan SM; Kim R
Curr Opin Gastroenterol; 2006 Nov; 22(6):669-73. PubMed ID: 17053447
[TBL] [Abstract][Full Text] [Related]
28. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
[TBL] [Abstract][Full Text] [Related]
29. Irritable bowel syndrome - The role of complementary medicines in treatment.
Pirotta M
Aust Fam Physician; 2009 Dec; 38(12):966-8. PubMed ID: 20369148
[TBL] [Abstract][Full Text] [Related]
30. The use of probiotics in the treatment of irritable bowel syndrome: two case reports.
Faber S; Rigden S; Lukaczer D
Altern Ther Health Med; 2005; 11(4):60-2. PubMed ID: 16053123
[No Abstract] [Full Text] [Related]
31. Metabonomic understanding of probiotic effects in humans with irritable bowel syndrome.
Hong YS; Hong KS; Park MH; Ahn YT; Lee JH; Huh CS; Lee J; Kim IK; Hwang GS; Kim JS
J Clin Gastroenterol; 2011; 45(5):415-25. PubMed ID: 21494186
[TBL] [Abstract][Full Text] [Related]
32. Treating irritable bowel syndrome with probiotics: the evidence.
Parkes GC; Sanderson JD; Whelan K
Proc Nutr Soc; 2010 May; 69(2):187-94. PubMed ID: 20236566
[TBL] [Abstract][Full Text] [Related]
33. Review article: probiotics for the treatment of irritable bowel syndrome--focus on lactic acid bacteria.
Clarke G; Cryan JF; Dinan TG; Quigley EM
Aliment Pharmacol Ther; 2012 Feb; 35(4):403-13. PubMed ID: 22225517
[TBL] [Abstract][Full Text] [Related]
34. Effects of symbiotic preparations on constipated irritable bowel syndrome symptoms.
Dughera L; Elia C; Navino M; Cisarò F;
Acta Biomed; 2007 Aug; 78(2):111-6. PubMed ID: 17933278
[TBL] [Abstract][Full Text] [Related]
35. The use of probiotics in the treatment of irritable bowel syndrome.
Gaby AR
Altern Ther Health Med; 2006; 12(1):17; author reply 17. PubMed ID: 16454141
[No Abstract] [Full Text] [Related]
36. [Postinfectious irritable bowel syndrome].
Döbrönte Z; Lakner L; Sarang K
Orv Hetil; 2006 Oct; 147(43):2077-80. PubMed ID: 17297754
[TBL] [Abstract][Full Text] [Related]
37. Potential future therapies for irritable bowel syndrome: will disease modifying therapy as opposed to symptomatic control become a reality?
Spiller RC
Gastroenterol Clin North Am; 2005 Jun; 34(2):337-54. PubMed ID: 15862939
[TBL] [Abstract][Full Text] [Related]
38. Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome - a randomized, double-blind, controlled study.
Simrén M; Ohman L; Olsson J; Svensson U; Ohlson K; Posserud I; Strid H
Aliment Pharmacol Ther; 2010 Jan; 31(2):218-27. PubMed ID: 19863495
[TBL] [Abstract][Full Text] [Related]
39. Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant. Results of an open, uncontrolled multicenter study.
Colecchia A; Vestito A; La Rocca A; Pasqui F; Nikiforaki A; Festi D;
Minerva Gastroenterol Dietol; 2006 Dec; 52(4):349-58. PubMed ID: 17108864
[TBL] [Abstract][Full Text] [Related]
40. [Probiotic therapy of the irritable bowel syndrome].
Enck P; Klosterhalfen S; Martens U
Dtsch Med Wochenschr; 2011 Feb; 136(8):371-5. PubMed ID: 21332036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
